Seneca House Advisors’s CVS Health CVS Stock Holding History

Seneca House Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-63,750	Closed	-$4.41M	–	79
2023 Q2	$4.41M	Buy	63,750 +15,912	+33%	+$1.13M	2.2%	19
2023 Q1	$3.55M	Buy	47,838 +8,574	+22%	+$719K	1.85%	21
2022 Q4	$3.66M	Buy	39,264 +22,850	+139%	+$2.2M	2.02%	18
2022 Q3	$1.56M	Buy	16,414 +758	+5%	+$75K	1.16%	28
2022 Q2	$1.45M	Buy	15,656 +1,277	+9%	+$125K	0.95%	34
2022 Q1	$1.46M	Buy	14,379 +2,708	+23%	+$284K	0.77%	36
2021 Q4	$1.2M	Buy	11,671 +3,120	+36%	+$288K	0.64%	39
2021 Q3	$726K	Buy	8,551 +723	+9%	+$60.6K	0.44%	49
2021 Q2	$653K	Buy	7,828 +305	+4%	+$25K	0.42%	40
2021 Q1	$566K	Buy	7,523 +1,213	+19%	+$88.4K	0.4%	39
2020 Q4	$431K	Buy	+6,310	New	+$410K	0.31%	49

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Seneca House Advisors's CVS Position: Q3 2023 in Review

Seneca House Advisors sold out of CVS Health (CVS) in Q3 2023, closing a stake of 63,750 shares — an estimated $4.41M sold.

Seneca House Advisors first reported a position in CVS in Q4 2020 and held it in 11 quarters. The position peaked at $4.41M in Q2 2023. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Seneca House Advisors reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
Seneca House Advisors sold 63,750 CVS Health shares in Q3 2023, an estimated $4.41M.
Seneca House Advisors first reported a position in CVS Health in Q4 2020 and held it in 11 quarters.
Seneca House Advisors's CVS Health position peaked at $4.41M in Q2 2023.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Seneca House Advisors's 13F filing for Q3 2023, filed 13 Oct 2023.